News|Videos|May 19, 2025

Compounded GLP-1 RA drugs: Criteria for compounding medicines to fill gaps that drugmakers can’t fill

Fact checked by: Todd Shryock

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

There are three criteria for compounding pharmacists to mix a version of a medicine that is not available from a pharmaceutical manufacturer. Scott Brunner, CEO of the Alliance for Pharmacy Compounding offers this tutorial and examples of how compounding pharmacists meet patient demand for necessary drugs.

Newsletter

Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.

Subscribe Now!

Related Content

Latest CME

Burst CME: Targeted Therapy for Optimal Psoriasis Management
Video

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

View more
Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management
Video

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

View more